All parents want their kids to be safe and healthy. But unless you have supermom or superdad powers, there are some things that you unfortunately cannot protect your child from, such as sickness. Imagine if you could purchase “insurance” now that you could use in the future if your child ever gets sick. Well that insurance is umbilical cord banking and you can. The blood from the umbilical cord is rich in stem cells and has been used to treat over 80 diseases to date. StemCyte, a global leader in private and public cord banking, offers parents the opportunity to preserve their baby’s potentially life-saving stem cells.
What’s more, StemCyte will be at the upcoming New York Baby Show on May 20 and 21, at Pier 94.
The nation’s biggest show for expectant and new families, the NEW YORK BABY SHOW is a wonderful family-friendly mega-event featuring everything to do with maternity, baby, and toddler. From top products to trusted parenting experts, the New York Baby Show welcomes thousands of expectant and new parents from New York City, the Tri-State area, and beyond!
Tickets to the New York Baby Show are $30 per family, and $20 per individual.
We spoke with a member of the StemCyte team, Christina Zhu, to learn more about the company and what new parents can expect at the New York Baby Show.
For someone unfamiliar with StemCyte, how would you describe the company’s mission and core offerings?
StemCyte is a global leading cord blood therapeutic company that offers public and private cord blood banking. StemCyte is dedicated to helping the world’s physicians save more lives by providing high-quality, safe, and effective stem cell transplantation and therapy to all patients in need.
Tell us about StemCyte. When did it start? How has it evolved over time?
StemCyte began its corporate “life” as a Public Umbilical Cord Blood (UCB) Bank with a mission to create the largest, most racially diverse UCB bank in the world to serve ALL patients in need. StemCyte has stayed true to this mission with its operations in the U.S.A., Taiwan, and India. No other UCB bank has accomplished a similar level of diversity or has treated as many patients around the world. StemCyte is truly an International UCB stem cell therapeutics company, having shipped over 2,000 UCB units from its public bank to leading hospitals around the world.
The culture of StemCyte and the attitude of our employees is based on this mission, and the same is true in the U.S.A., Taiwan, and India. Because our “roots” are as a Public UCB Bank, we operate by the highest standards in the world, and each unit that we collect and save—public and private—is treated in the same way. For example, as if that specific unit will be used to save a life in the future. The result is that StemCyte provides the BEST service to our customers, and gives them peace of mind and the utmost confidence that their child’s UCB is being handled by the best UCB professionals in the world.
What are the most popular and newest products from StemCyte?
StemCyte currently offers cord blood banking at costs starting at $1,195 with an annual storage fee of $150 per year, and cord blood and cord tissue banking at costs starting at $1,990 with an annual storage fee of $275 per year. StemCyte offers affordable payment plans, using the client’s credit card to pay the initial enrollment fee over the course of six months to one year.
Also, StemCyte offers a virtual baby shower program that gives family, friends, and co-workers of our clients the opportunity to donate towards the cost of banking. Our “Refer-A-Friend” program is also a great way for clients to pass on their positive experience with StemCyte by recommending StemCyte to their friends. When they do, they will receive either a free year of storage for themselves, or they can give it as a gift to their friend, or receive $100 cash back when their friend banks with StemCyte.
What sets StemCyte apart from other companies?
The fact that we have a very large and diverse Public UCB Bank—a valuable asset that StemCyte owns—has allowed us to develop an Advanced Therapeutics initiative and to partner with leading researchers and clinicians in the U.S.A., Taiwan, HK, China, and India. This initiative has led to clinical trials to develop UCB to treat Thalassemia, chronic and acute stroke, as well as chronic and acute spinal cord injury. And this is only the beginning. No other UCB company in the world has a multinational presence and no other UCB company in the world can state that they have our three component business model.
What can parents except to see from Stemcyte at the New York Baby Show?
StemCyte cord blood specialists will be onsite and ready to answer any questions expectant parents might have regarding cord blood and/or cord tissue banking. Expectant parents can always call 866.389.4659 or visit StemCyte.com for more information.
For more information, check out stemcyte.com!